Syner-KINASE® (urokinase)

Product category 

Therapy area 

  • Renal
  • Oncology

Syner-KINASE® (urokinase) is licensed in the UK for the treatment of thrombosed catheters and systemic thromboembolic occlusive disease (diseases caused by blood clots). 

Syner-KINASE® is available in the UK in vials of 10,000 IU, 25,000 IU and 100,000 IU.
 
The catheter lock dose is up to 25,000 IU per lumen and can be administered using the dwell-lock or push-lock technique.
 
Alternatively an infusion of up to 250,000 IU of Syner-KINASE® can be administered into the catheter over a period of 90 to 180 minutes.
 
Syner-KINASE® (urokinase) is the only urokinase in the UK free of human albumin

Downloads: 

HEALTHCARE PROFESSIONAL DOWNLOADS
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Syner-Med (Pharmaceutical Products) Limited. Tel. +44 020 8655 6380

Leave us a message

CONTACT US

International headquarters
Syner-Med (Pharmaceutical Products) Ltd.
Syner-Med House
120 High Street
Purley, Surrey
CR8 2AD, United Kingdom

Tel: +44 (0)20 8655 6380
E: mail@syner-med.com

Are you a healthcare professional?

To access this section of the Syner-Med Pharmaceutical Products Limited website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.

Please click on the appropriate button below to confirm that you are a healthcare professional. If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.

I am a healthcare professional

I am not a healthcare professional